Overview

The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Nephritis

Status:
Terminated

Trial end date:
2013-01-01

Target enrollment:

Participant gender:

Summary

To investigate the efficacy and safety of enteric-coated mycophenolate sodium (Myfortic) as compared to intravenous cyclophosphamide in the treatment of active nephritis. The primary outcomes are complete and partial renal remission, as assessed by renal function, urinary sediment and proteinuria in patients with International Society of Nephrology/ Renal Pathology Society (ISN/RPS) class III or IV lupus nephritis.

Phase:

Phase 3

Details

Lead Sponsor:

Chulalongkorn University

Collaborators:

Clinical Research Collaborative Network
Health Intervention and Technology Assessment Program (HITAP)

Treatments:

Cyclophosphamide
Mycophenolate mofetil
Mycophenolic Acid